What's breaking now, across thousands of outlets.
The company Atlas Bio is improving the success rate of clinical trials, which so far have seen 70 percent of all drugs fail. To do this, the start-up is now raising $11 million.
We haven't written up this one. Handelsblatt has the full story — the link below goes straight to it.
This is one outlet's version. Read the fullest account.
COVID and MAHA weren't just dangerous, they were obviously dangerous. Yet, there was a coordinated effort to numb people to their risks, The post The Novocaine Pushers: Numbing People to Obvious…
Fred Ojeh National Institute for Cancer Research and Treatment (NICRAT), to advance the implementation of Nigeria’s National Cancer Biobank Network (NCBN), a nationally coordinated initiative designed…
<p>Doha, Qatar: Hamad Medical Corporation (HMC) has achieved two significant milestones, with Al Wakra Hospital receiving Gold Certification and Heart Hospital receiving Silver Certification for…
A severe nationwide shortage of seasonal influenza vaccines has hit public and private healthcare sectors across Pakistan.
Researchers at the Norwegian University of Science and Technology have found that JAK inhibitors may weaken the body's defenses.
While leaving open the possibility of an undetected chain in Uganda.
